Pediatric gastrointestinal stromal tumors.

[1]  C. Antonescu,et al.  Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations , 2010, Proceedings of the National Academy of Sciences.

[2]  E. Wardelmann,et al.  Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour , 2010, The British journal of surgery.

[3]  J. Blay,et al.  Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors , 2010, Cancer.

[4]  P. Pisters,et al.  Gastrointestinal stromal tumors: Current management , 2010, Journal of surgical oncology.

[5]  P. Bénit,et al.  SDHA is a tumor suppressor gene causing paraganglioma. , 2010, Human molecular genetics.

[6]  R. Barr.  Imatinib mesylate in children and adolescents with cancer , 2010, Pediatric blood & cancer.

[7]  C. Antonescu,et al.  Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG Z9001. , 2010 .

[8]  J. Blay,et al.  Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST). , 2010, European journal of cancer.

[9]  C. Antonescu,et al.  NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[10]  E. Wardelmann,et al.  Gastrointestinal stromal tumors (GIST) in children and adolescents: A comprehensive review of the current literature , 2009, Pediatric blood & cancer.

[11]  H. Joensuu,et al.  Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. , 2009, European journal of cancer.

[12]  E. van Marck,et al.  An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. , 2009, The Lancet. Oncology.

[13]  A. D. Van den Abbeele,et al.  Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib , 2009, Pediatric blood & cancer.

[14]  W. Brugge,et al.  A guide for the diagnosis and management of gastrointestinal stromal cell tumors , 2009, Nature Reviews Gastroenterology &Hepatology.

[15]  K. Lok,et al.  Endosonographic surveillance of small gastrointestinal tumors originating from muscularis propria. , 2009, Journal of gastrointestinal and liver diseases : JGLD.

[16]  M. Schlemmer,et al.  Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  C. Antonescu,et al.  Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[18]  R. DeMatteo,et al.  Management of resectable gastrointestinal stromal tumor. , 2009, Hematology/oncology clinics of North America.

[19]  U. Klinge,et al.  The Gist of Literature on Pediatric GIST: Review of Clinical Presentation , 2009, Journal of pediatric hematology/oncology.

[20]  C. Antonescu,et al.  Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  K. Owzar,et al.  Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Scarpa,et al.  A systematic review on the clinical diagnosis of gastrointestinal stromal tumors , 2008, Journal of surgical oncology.

[23]  Narasimhan P. Agaram,et al.  Novel V600E BRAF mutations in imatinib‐naive and imatinib‐resistant gastrointestinal stromal tumors , 2008, Genes, chromosomes & cancer.

[24]  C. Braconi,et al.  Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  D. Flieder,et al.  Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors , 2008, Proceedings of the National Academy of Sciences.

[26]  Narasimhan P. Agaram,et al.  Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors , 2008, Clinical Cancer Research.

[27]  S. Ashley,et al.  How I Do It: Surgical Management of Gastrointestinal Stromal Tumors , 2008, Journal of Gastrointestinal Surgery.

[28]  I. Judson,et al.  Treatment of wild‐type gastrointestinal stromal tumor (WT‐GIST) with imatinib and sunitinib , 2008, Pediatric blood & cancer.

[29]  A. Verschuur,et al.  Respiratory symptoms in a boy revealing Carney triad , 2008, Pediatric blood & cancer.

[30]  J. Crowley,et al.  Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  J. Fletcher,et al.  Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  P. Adamson,et al.  A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: A Children's Oncology Group study , 2008, Pediatric blood & cancer.

[33]  J. Fletcher,et al.  Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors. , 2007, Cancer research.

[34]  M. Choi,et al.  Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[35]  C. Stratakis,et al.  Familial gastrointestinal stromal tumors and germ-line mutations. , 2007, The New England journal of medicine.

[36]  P. Tounian,et al.  Pediatric Jejunal Gastrointestinal Stromal Tumor Diagnosed by Wireless Capsule Endoscopy , 2007, Journal of pediatric gastroenterology and nutrition.

[37]  E. Campo,et al.  Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. , 2007, The Journal of clinical endocrinology and metabolism.

[38]  R. Krueger,et al.  Carney's triad: a 16-year follow-up. , 2007, Journal of pediatric surgery.

[39]  C. Antonescu,et al.  Outcome of Metastatic GIST in the Era before Tyrosine Kinase Inhibitors , 2007, Annals of Surgical Oncology.

[40]  M. Kay,et al.  The endoscopic appearance of a gastrointestinal stromal tumor in a pediatric patient. , 2007, Journal of pediatric surgery.

[41]  A. D. Van den Abbeele,et al.  NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

[42]  T. Nishida,et al.  Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection , 2007, Surgical Endoscopy.

[43]  M. Chiarugi,et al.  Gastrointestinal stromal tumour of the duodenum in childhood: a rare case report , 2007, BMC Cancer.

[44]  P. Rutkowski,et al.  Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor , 2007, Annals of Surgical Oncology.

[45]  Haesun Choi,et al.  We should desist using RECIST, at least in GIST. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  Haesun Choi,et al.  Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  K. Akahoshi,et al.  Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration. , 2007, World journal of gastroenterology.

[48]  J. Jónasson,et al.  Clinical Study on Gastrointestinal Stromal Tumors (GIST) in Iceland, 1990–2003 , 2007, Digestive Diseases and Sciences.

[49]  J. Vermeesch,et al.  Array CGH analysis in primary gastrointestinal stromal tumors: Cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status , 2007, Genes, chromosomes & cancer.

[50]  C. Antonescu,et al.  Results of Tyrosine Kinase Inhibitor Therapy Followed by Surgical Resection for Metastatic Gastrointestinal Stromal Tumor , 2007, Annals of surgery.

[51]  P. Casali,et al.  Surgery of Residual Disease Following Molecular-targeted Therapy With Imatinib Mesylate in Advanced/Metastatic GIST , 2007, Annals of surgery.

[52]  H. Gadner,et al.  CLINICAL, RADIOLOGICAL, AND PATHOLOGICAL FINDINGS IN FOUR CHILDREN WITH GASTROINTESTINAL STROMAL TUMORS OF THE STOMACH , 2007, Pediatric hematology and oncology.

[53]  Narasimhan P. Agaram,et al.  Pathologic and Molecular Heterogeneity in Imatinib-Stable or Imatinib-Responsive Gastrointestinal Stromal Tumors , 2007, Clinical Cancer Research.

[54]  Xin Huang,et al.  Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial , 2006, The Lancet.

[55]  L. Fordham,et al.  Multifocal gastrointestinal stromal tumor (GIST) of the stomach in an 11-year-old girl , 2006, Pediatric Radiology.

[56]  P. Terrier,et al.  Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era , 2006, Annals of Surgical Oncology.

[57]  E. Gottlieb,et al.  Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.

[58]  M. Bolland,et al.  Gastrointestinal stromal tumour in succinate dehydrogenase subunit B mutation‐associated familial phaeochromocytoma/paraganglioma , 2006, ANZ journal of surgery.

[59]  D. Faigel,et al.  Yield of tissue sampling for subepithelial lesions evaluated by EUS: a comparison between forceps biopsies and endoscopic submucosal resection. , 2006, Gastrointestinal endoscopy.

[60]  M. Kimmey,et al.  American Gastroenterological Association Institute technical review on the management of gastric subepithelial masses. , 2006, Gastroenterology.

[61]  Y. Novitsky,et al.  Long-term Outcomes of Laparoscopic Resection of Gastric Gastrointestinal Stromal Tumors , 2006, Annals of surgery.

[62]  J. Desai,et al.  Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  J. Lasota,et al.  Gastrointestinal stromal tumors: pathology and prognosis at different sites. , 2006, Seminars in diagnostic pathology.

[64]  J. Blay,et al.  KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. , 2006, European journal of cancer.

[65]  L. Koniaris,et al.  Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. , 2006, Journal of the American College of Surgeons.

[66]  F. Ris,et al.  An audit of surgical management of gastrointestinal stromal tumours (GIST). , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[67]  T. Kubota,et al.  Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases. , 2006, Surgery.

[68]  J. Blay,et al.  Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[69]  Eyal Gottlieb,et al.  Mitochondrial tumour suppressors: a genetic and biochemical update , 2005, Nature Reviews Cancer.

[70]  M. O'sullivan,et al.  Multiple Gastric Stromal Tumors in a Child without Syndromic Association Lacks Common KIT or PDGFRα Mutations , 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[71]  J. Jónasson,et al.  Gastrointestinal stromal tumors in Iceland, 1990–2003: The Icelandic GIST study, a population‐based incidence and pathologic risk stratification study , 2005, International journal of cancer.

[72]  Y. Hayashi,et al.  Advanced-stage gastrointestinal stromal tumor treated with imatinib in a 12-year-old girl with a unique mutation of PDGFRA. , 2005, Journal of pediatric surgery.

[73]  Y. Kajiyama,et al.  Gastrointestinal stromal tumor in a child and review of the literature , 2005, Pediatric Surgery International.

[74]  L. Sobin,et al.  Gastrointestinal Stromal Tumors of the Stomach in Children and Young Adults: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 44 Cases With Long-Term Follow-Up and Review of the Literature , 2005, The American journal of surgical pathology.

[75]  M. Levy,et al.  EUS-guided Trucut biopsy. , 2005, Gastrointestinal endoscopy.

[76]  M. Kimmey,et al.  A prospective study comparing endoscopy and EUS in the evaluation of GI subepithelial masses. , 2005, Gastrointestinal endoscopy.

[77]  A. Pappo,et al.  Clinical and molecular characteristics of pediatric gastrointestinal stromal tumors (GISTs) , 2005, Pediatric blood & cancer.

[78]  M. Pólkowski.  Endoscopic Ultrasound and Endoscopic Ultrasound-Guided Fine-Needle Biopsy for the Diagnosis of Malignant Submucosal Tumors , 2005, Endoscopy.

[79]  M. van de Rijn,et al.  Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  N. Socci,et al.  Gastrointestinal Stromal Tumors in Children and Young Adults: A Clinicopathologic, Molecular, and Genomic Study of 15 Cases and Review of the Literature , 2005, Journal of pediatric hematology/oncology.

[81]  J. Blay,et al.  Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[82]  Edward Y Lee,et al.  Gastrointestinal stromal tumor (GIST) of stomach in a pediatric patient , 2005, Pediatric Radiology.

[83]  B. Nilsson,et al.  Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era , 2005, Cancer.

[84]  H. Yasui,et al.  A case of pediatric gastrointestinal stromal tumor of the stomach , 2005, Pediatrics international : official journal of the Japan Pediatric Society.

[85]  M. Bernstein,et al.  Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study. , 2004, Blood.

[86]  J. Fletcher,et al.  Biology of gastrointestinal stromal tumors. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  A. Pappo,et al.  Pediatric gastrointestinal stromal tumors and leiomyosarcoma , 2004, Cancer.

[88]  V. Chen,et al.  Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound‐guided fine‐needle aspiration biopsy , 2004, Cancer.

[89]  D. Faigel,et al.  Yield of tissue sampling for submucosal lesions evaluated by EUS. , 2004, Gastrointestinal endoscopy.

[90]  S. Mocellin,et al.  Gastrointestinal stromal tumors: From a surgical to a molecular approach , 2003, International journal of cancer.

[91]  I. Waxman,et al.  Clinical Impact of On-Site Cytopathology Interpretation on Endoscopic Ultrasound-Guided Fine Needle Aspiration , 2003, American Journal of Gastroenterology.

[92]  G. Guerrero-Avendaño,et al.  Gastrointestinal stromal tumor in a patient surviving osteosarcoma. , 2003, Medical and pediatric oncology.

[93]  D. Faigel,et al.  A comparison of EUS features between CD-117 positive GI stromal tumors and CD-117 negative GI spindle cell tumors. , 2003, Gastrointestinal endoscopy.

[94]  B. Gunawan,et al.  Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours , 2003, The British journal of surgery.

[95]  Samuel Singer,et al.  PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors , 2003, Science.

[96]  V. Chen,et al.  Endoscopic ultrasound‐guided fine‐needle aspiration biopsy , 2002, Cancer.

[97]  A. D. Van den Abbeele,et al.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. , 2002, The New England journal of medicine.

[98]  A. West,et al.  Epithelioid Gastrointestinal Stromal Tumor of the Stomach with Liver Metastases in a 12-Year-old Girl: Aspiration Cytology and Molecular Study , 2002, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[99]  J. Fletcher,et al.  Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. , 2002, Human pathology.

[100]  L. Sobin,et al.  Diagnosis of gastrointestinal stromal tumors: A consensus approach. , 2002, Human pathology.

[101]  N. Soehendra,et al.  Impact of endoscopic ultrasound for evaluation of submucosal lesions in gastrointestinal tract. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[102]  C. Stratakis,et al.  Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. , 2002, American journal of medical genetics.

[103]  J. W. Griffin,et al.  Gastrointestinal Autonomic Nerve Tumor: Immunohistochemical and Molecular Identity With Gastrointestinal Stromal Tumor , 2001, The American journal of surgical pathology.

[104]  M. Debiec‐Rychter,et al.  Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation. , 2001, Cancer genetics and cytogenetics.

[105]  D. Johnston,et al.  Gastrointestinal stromal tumor in a patient with previous neuroblastoma. , 2001, Journal of pediatric hematology/oncology.

[106]  D. Evans,et al.  Germline SDHD mutation in familial phaeochromocytoma , 2001, The Lancet.

[107]  Ulrich Müller,et al.  Mutations in SDHC cause autosomal dominant paraganglioma, type 3 , 2000, Nature Genetics.

[108]  R. Feakins,et al.  Congenital gastrointestinal stromal tumour is morphologically indistinguishable from the adult form, but does not express CD117 and carries a favourable prognosis , 2000, Histopathology.

[109]  L. Sobin,et al.  Immunohistochemical Spectrum of GISTs at Different Sites and Their Differential Diagnosis with a Reference to CD117 (KIT) , 2000, Modern Pathology.

[110]  S. Knuutila,et al.  DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. , 2000, Cancer research.

[111]  Koutaro Ichikawa,et al.  Clinical and histopathological features of colonic stromal tumor in a child , 2000, Journal of Gastroenterology.

[112]  E. Melzer,et al.  The natural course of upper gastrointestinal submucosal tumors: an endoscopic ultrasound survey. , 2000, The Israel Medical Association journal : IMAJ.

[113]  Hoguen Kim,et al.  Putative chromosomal deletions on 9p, 9q and 22q occur preferentially in malignant gastrointestinal stromal tumors , 2000, International journal of cancer.

[114]  B. Devlin,et al.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.

[115]  L. Palazzo,et al.  Endosonographic features predictive of benign and malignant gastrointestinal stromal cell tumours , 2000, Gut.

[116]  S. Peng,et al.  Congenital gastrointestinal pacemaker cell tumor. , 1999, Archives of pathology & laboratory medicine.

[117]  Wan Ariffin Bin Abdullah,et al.  Med Pediatr Oncol , 1999 .

[118]  J. Carney,et al.  Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. , 1999, Mayo Clinic proceedings.

[119]  A. Sahai,et al.  Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience , 1999, Gut.

[120]  S. Sredni,et al.  Association of gastrointestinal stromal tumor (leiomyosarcoma), pulmonary chondroma, and nonfunctional retroperitoneal paraganglioma. , 1998, Medical and pediatric oncology.

[121]  C. Fletcher,et al.  Gastrointestinal Stromal Tumours: An Update , 1998, Sarcoma.

[122]  S. Hirota,et al.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. , 1998, Science.

[123]  S. Carpenter,et al.  Endosonographic differentiation of benign and malignant stromal cell tumors. , 1997, Gastrointestinal endoscopy.

[124]  J. Seitz,et al.  Fine-Needle Aspiration Cytology Guided by Endoscopic Ultrasonography: Results in 141 Patients , 1995, Endoscopy.

[125]  M. Wiersema,et al.  Combined endosonography and fine-needle aspiration cytology in the evaluation of gastrointestinal lesions. , 1994, Gastrointestinal endoscopy.

[126]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[127]  J. Hedenbro,et al.  Endoscopic diagnosis of submucosal gastric lesions , 1991, Surgical Endoscopy.

[128]  M. Mazur,et al.  Gastric stromal tumors Reappraisal of histogenesis , 1983, The American journal of surgical pathology.

[129]  Liang-Che Chang,et al.  The role of endoscopic ultrasonography examination for evaluation and surveillance of gastric subepithelial masses. , 2010, Chang Gung medical journal.

[130]  Jean-Yves Scoazec,et al.  BRAF mutation status in gastrointestinal stromal tumors. , 2010, American journal of clinical pathology.

[131]  J. Ellison,et al.  Clinical and molecular genetics of patients with the Carney–Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD , 2008, European Journal of Human Genetics.

[132]  J. Clain,et al.  Preliminary experience with an EUS-guided trucut biopsy needle compared with EUS-guided FNA. , 2003, Gastrointestinal endoscopy.

[133]  Y. Hirooka,et al.  The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. , 2002, Gastrointestinal endoscopy.

[134]  A. Davis,et al.  Malignant Gastrointestinal Stromal Tumors of the Small Intestine: A Review of 50 Cases From a Prospective Database , 2001, Annals of Surgical Oncology.

[135]  M. Catalano,et al.  Interobserver agreement for EUS in the evaluation and diagnosis of submucosal masses. , 2001, Gastrointestinal endoscopy.

[136]  S. Singh,et al.  Gastrointestinal stromal tumor: a rare cause of neonatal intestinal obstruction. , 2000, Medical and pediatric oncology.

[137]  R. DeMatteo,et al.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. , 2000, Annals of surgery.

[138]  M. Chintagumpala,et al.  Gastrointestinal autonomic nerve tumors in the pediatric population , 1999, Cancer.